Recent progress in protein-protein interaction study for EGFR-targeted therapeutics

Feiner R, Müller K (2016)
Expert Review of Proteomics 13(9): 817-832.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Abstract / Bemerkung
Introduction: Epidermal growth factor receptor (EGFR) expression is upregulated in many tumors and its aberrant signaling drives progression of many cancer types. Consequently, EGFR has become a clinically validated target as extracellular tumor marker for antibodies as well as for tyrosine kinase inhibitors. Within the last years, new mechanistic insights were uncovered and, based on clinical experience as well as progress in protein engineering, novel bio-therapeutic approaches were developed and tested.Areas covered: The potential therapeutic targeting arsenal in the fight against cancer now encompasses bispecific or biparatopic antibodies, DARPins, Adnectins, Affibodies, peptides and combinations of these binding molecules with viral- and nano-particles. We review past and recent binding proteins from the literature and include a brief description of the various targeting approaches. Special attention is given to the binding modes with the EGFR.Expert commentary: Clinical data from the three approved anti EGFR antibodies indicate that there is room for improved therapeutic efficacy. Having choices in size, affinity, avidity and the mode of EGFR binding as well as the possibility to combine various effector functions opens the possibility to rationally design more effective therapeutics.
Erscheinungsjahr
Zeitschriftentitel
Expert Review of Proteomics
Band
13
Zeitschriftennummer
9
Seite
817-832
ISSN
eISSN
PUB-ID

Zitieren

Feiner R, Müller K. Recent progress in protein-protein interaction study for EGFR-targeted therapeutics. Expert Review of Proteomics. 2016;13(9):817-832.
Feiner, R., & Müller, K. (2016). Recent progress in protein-protein interaction study for EGFR-targeted therapeutics. Expert Review of Proteomics, 13(9), 817-832. doi:10.1080/14789450.2016.1212665
Feiner, R., and Müller, K. (2016). Recent progress in protein-protein interaction study for EGFR-targeted therapeutics. Expert Review of Proteomics 13, 817-832.
Feiner, R., & Müller, K., 2016. Recent progress in protein-protein interaction study for EGFR-targeted therapeutics. Expert Review of Proteomics, 13(9), p 817-832.
R. Feiner and K. Müller, “Recent progress in protein-protein interaction study for EGFR-targeted therapeutics”, Expert Review of Proteomics, vol. 13, 2016, pp. 817-832.
Feiner, R., Müller, K.: Recent progress in protein-protein interaction study for EGFR-targeted therapeutics. Expert Review of Proteomics. 13, 817-832 (2016).
Feiner, Rebecca, and Müller, Kristian. “Recent progress in protein-protein interaction study for EGFR-targeted therapeutics”. Expert Review of Proteomics 13.9 (2016): 817-832.

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 27424502
PubMed | Europe PMC

Suchen in

Google Scholar